Create SD Holdings Co., Ltd. (TYO:3148)
2,839.00
+62.00 (2.23%)
Mar 12, 2025, 3:30 PM JST
Create SD Holdings Revenue
Create SD Holdings had revenue of 110.91B JPY in the quarter ending November 30, 2024, with 7.29% growth. This brings the company's revenue in the last twelve months to 439.69B, up 9.64% year-over-year. In the fiscal year ending May 31, 2024, Create SD Holdings had annual revenue of 422.33B with 10.86% growth.
Revenue (ttm)
439.69B
Revenue Growth
+9.64%
P/S Ratio
0.41
Revenue / Employee
91.66M
Employees
4,797
Market Cap
183.21B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 31, 2024 | 422.33B | 41.37B | 10.86% |
May 31, 2023 | 380.96B | 30.22B | 8.62% |
May 31, 2022 | 350.74B | 12.27B | 3.62% |
May 31, 2021 | 338.48B | 18.89B | 5.91% |
May 31, 2020 | 319.59B | 33.29B | 11.63% |
May 31, 2019 | Pro | Pro | Pro |
May 31, 2018 | Pro | Pro | Pro |
May 31, 2017 | Pro | Pro | Pro |
May 31, 2016 | Pro | Pro | Pro |
May 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Otsuka Holdings | 2,329.86B |
Terumo | 1,011.15B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |